Please use this identifier to cite or link to this item:
|Title:||The Vaccines Consistency Approach Project: an EPAA Initiative|
|Authors:||DE MATTIA Fabrizio; HENDRIKSEN Coenraad; BUCHHEIT Karl-Heinz; CHAPSAL Jean-Michel; HALDER Maria; LAMBRIGTS Denis; REDHEAD Keith; ROMMEL Eddy; SCHARTON-KERSTEN Tanya; SESARDIC Thea; VIVANI Laura; RAGAN Ian|
|Citation:||PHARMEUROPA BIO & SCIENTIFIC NOTES p. 30-56|
|Publisher:||EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES|
|Type:||Articles in periodicals and books|
|Abstract:||The consistency approach for release testing of established vaccines promotes the use of in vitro, analytical, non-animal based systems allowing the monitoring of quality parameters during the whole production process. By using highly sensitive non-animal methods, the consistency approach has the potential to improve the quality of testing and to foster the 3Rs (replacement, refinement and reduction of animal use) for quality control of established vaccines. This concept offers an alternative to the current quality control strategy which often requires large numbers of laboratory animals. In order to facilitate the introduction of the consistency approach for established human and veterinary vaccine quality control, the European Partnership for Alternatives to Animal Testing (EPAA) initiated a project, the “Vaccines Consistency Approach Project”, aiming at developing and validating the consistency approach with stakeholders from academia, regulators, OMCLs, EDQM, European Commission and industry. This report summarises progress since the project’s inception.|
|JRC Directorate:||Institute for Health and Consumer Protection Historical Collection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.